Bone-targeted therapy for advanced androgen-independent carcinoma of the prostate: a randomised phase II trial
Top Cited Papers
- 1 February 2001
- journal article
- clinical trial
- Published by Elsevier in The Lancet
- Vol. 357 (9253), 336-341
- https://doi.org/10.1016/s0140-6736(00)03639-4
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Osteomimetic properties of prostate cancer cells: A hypothesis supporting the predilection of prostate cancer metastasis and growth in the bone environmentThe Prostate, 1999
- Prognostic Significance of Extent of Disease in Bone in Patients With Androgen-Independent Prostate CancerJournal of Clinical Oncology, 1999
- Mechanisms of the development of osteoblastic metastasesCancer, 1997
- Efficacy of Pamidronate in Reducing Skeletal Events in Patients with Advanced Multiple MyelomaNew England Journal of Medicine, 1996
- Orchiectomy versus goserelin and flutamide in the treatment of newly diagnosed metastatic prostate cancer. Analysis of the criteria of evaluation used in the european organization for research and treatment of cancer–-genitourinary group study 30853Cancer, 1993
- Results of a randomized phase-III trial to evaluate the efficacy of strontium-89 adjuvant to local field external beam irradiation in the management of endocrine resistant metastatic prostate cancerInternational Journal of Radiation Oncology*Biology*Physics, 1993
- Strontium-89: treatment results and kinetics in patients with painful metastatic prostate and breast cancer in bone.RadioGraphics, 1989
- Stratification of patients with metastatic prostate cancer based on extent of disease on initial bone scanCancer, 1988
- Survival Following Aggressive Resection of Pulmonary Metastases from Osteogenic Sarcoma: Analysis of Prognostic FactorsThe Annals of Thoracic Surgery, 1983
- Nuclear bone imaging in metastatic cancer of the prostateCancer, 1981